Use access key #2 to skip to page content.
$41.72 -0.97 (-2.27%)
5/16/2008 4:00 PM

ImClone Systems, Inc. (IMCL)

CAPS Rating:
***

A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.

View All Commentary (IMCL)

Recs

0

Avatar wwjb (49.32) Submitted: 4/15/08 1:30 PM : Outperform Start Price: $44.65 IMCL Score: -13.91

53

Report this Post Replies: 0 | Reply

Featured Broker Partners